Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerOpenAI sign Language
VIPCreated with Sketch.

Efficacy and safety of treatment with sofosbuvir/velpatasvir in patients aged 6-18 years with chronic hepatitis C-Results of the PANDAA-PED study.

Maria Pokorska-Śpiewak,Ewa Talarek,Małgorzata Aniszewska,Magdalena Pluta,Anna Dobrzeniecka,Magdalena Marczyńska,Giuseppe Indolfi

Liver international : official journal of the International Association for the Study of the Liver（2023）

Cited 1|Views9
No score
Abstract
Results of the PANDAA-PED study indicated a 100% effectiveness of a 12-week therapy with SOF/VEL in children aged 6-18 years with chronic HCV infection and its good safety profile, in particular in younger patients.
More
Translated text
Key words
children, direct acting antivirals, hepatitis C virus, sofosbuvir, velpatasvir
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined